Bharat Immunologicals & Biologicals Corporation Limited (BOM:524663)
India flag India · Delayed Price · Currency is INR
18.47
-0.35 (-1.86%)
At close: Feb 13, 2026

BOM:524663 Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Mar '23 Mar '22 Mar '21 Mar '20 Mar '19
Net Income
-166.39-87.54-181.13-102.11-57.93
Depreciation & Amortization
22.132.372.372.76
Other Operating Activities
4.9541.27296.94-1.52-18.19
Change in Accounts Receivable
-127.43-11.23176.03553.58-570.28
Change in Inventory
348.28-227.59382.28-372.8-127.18
Change in Accounts Payable
1.62-139.24-287.38-6.53437.66
Change in Unearned Revenue
-----13.84
Change in Other Net Operating Assets
45.91.05-271.35267.826.04
Operating Cash Flow
108.92-421.15117.77340.79-320.96
Operating Cash Flow Growth
---65.44%--
Capital Expenditures
----0.01-0.25
Other Investing Activities
4.625.316.699.137.23
Investing Cash Flow
4.625.316.699.126.98
Short-Term Debt Issued
-505.92242.55-322.22
Total Debt Issued
-505.92242.55-322.22
Short-Term Debt Repaid
-76.6---291.84-
Total Debt Repaid
-76.6---291.84-
Net Debt Issued (Repaid)
-76.6505.92242.55-291.84322.22
Other Financing Activities
-70.52-55.92-364.58-52.31-15.15
Financing Cash Flow
-147.12450-122.03-344.14307.07
Miscellaneous Cash Flow Adjustments
-----1
Net Cash Flow
-33.5734.162.435.77-7.9
Free Cash Flow
108.92-421.15117.77340.79-321.21
Free Cash Flow Growth
---65.44%--
Free Cash Flow Margin
24.42%-53.73%13.80%50.99%-38.40%
Free Cash Flow Per Share
2.52-9.752.737.89-7.44
Cash Interest Paid
70.4955.9247.7747.4220.04
Levered Free Cash Flow
125.24-476.84-172.27367.5-354.34
Unlevered Free Cash Flow
168.76-444.91-145392.89-345.23
Change in Working Capital
268.37-377.01-0.42442.06-247.59
Source: S&P Global Market Intelligence. Standard template. Financial Sources.